Pulmonary hypertension (PHT) is present in all children at birth, but its degree and rate of resolution in infants diagnosed with congenital diaphragmatic hernia (CDH) requiring extracorporeal membrane oxygenation (ECMO) need to be established.
STUDY DESIGN:
Twenty-one ECMO/CDH survivors (aged 3.2 Ϯ 1.4 years) were prospectively evaluated by Doppler echocardiography (ECHO) to determine the presence of PHT. Twenty children without structural heart disease were used as controls. Study patients received a physical examination and an electrocardiograph examination, and their charts were reviewed for neonatal course data. Patients found to have PHT by ECHO received a complete history and exercise treadmill/oxygen desaturation study.
RESULTS:
Eight of the 21 patients (38%) met echocardiographic criteria for PHT. No neonatal course data were found to be predictive of eventual PHT status. There was no correlation between physical examination or electrocardiographic findings and PHT. Complete histories showed five of the eight patients with PHT had some degree of exercise intolerance and seven had wheezing. Two of the seven patients studied on the treadmill desaturated 5% or greater from baseline.
CONCLUSION:
There is evidence that PHT either persists or recurs in a significant portion of the ECMO/CDH population and may remain symptomatic well beyond the neonatal period.
Extracorporeal membrane oxygenation (ECMO) therapy is used routinely in many medical centers for the treatment of respiratory failure in neonates refractory to conventional management. According to the international ELSO (Extracorporeal Life Support Organization) registry, as of January 1997, over 20% of all neonates requiring ECMO presented with a primary diagnosis of congenital diaphragmatic hernia (CDH). 1 The CDH population remains unique among these ECMO recipients with lower survival rates and increased morbidity. [1] [2] [3] [4] Follow-up studies of CDH infants have reported additional sequelae during the first years of life, including neurocognitive delays and growth and feeding problems. [5] [6] [7] [8] However, given the degree of pulmonary hypoplasia and related pulmonary hypertension associated with CDH during the neonatal period, it seems appropriate that cardiopulmonary function should be more thoroughly evaluated in the ECMO/ CDH population. While anecdotal reports of ECMO/CDH survivors demonstrating persistent or recurrent pulmonary hypertension (PHT) exist, 9, 10 only one study to date has systematically evaluated this population to determine if pulmonary artery pressures remain elevated during early childhood. 6 The purpose of this study was fourfold: (1) to noninvasively assess whether pulmonary artery pressures (PAP) remained elevated well after the neonatal period; (2) to evaluate whether any variables could predict which infants are at an increased risk of developing PHT; (3) to assess the relative utility of physical examination and electrocardiography (ECG) to screen for persistent or recurrent PHT; and (4) to determine if PHT is clinically symptomatic and impacts on functional status.
MATERIALS AND METHODS
Thirty-eight infants transferred to the Children's Hospital of Philadelphia (CHOP) between December 1990 and April 1995 were diagnosed with CDH and required ECMO therapy. Twenty-six of the 38 (68%) patients survived. We attempted to contact all survivors both by letter and telephone to enroll them in this study. Four patients were unable to be assessed due to travel distance to the hospital. Another patient remained intubated at the time of the study and was subsequently excluded. The 21 remaining patients (mean age 3.2 Ϯ 1.4 years) had all been followed in the Neonatal Follow-Up Program since their initial hospital discharge and agreed to participate in the study. Clinical history and hospital course were not significantly different between the five patients excluded and those who remained available for eval-uation. Informed consent was obtained from each patient's parents or guardians for all procedures that would be performed. This study was approved by CHOP's Institutional Review Board.
Hospital records were reviewed on all patients to gather demographic, neonatal, and ECMO course data. These data included: gender, race, birth weight, gestational age, repair with a diaphragmatic patch, mode of ECMO, the last arterial blood gas measurements before going on ECMO, oxygenation index, number of hours on ECMO, and total duration of supplemental oxygen (including those needing greater than 30 and 90 days of oxygen). Supplemental oxygen was discontinued when patients were able to maintain oxygen saturations of Ն95% while in room air when asleep, eating, and awake.
The 21 patients were scheduled to return to CHOP for an echocardiogram (ECHO), an ECG, and a physical examination. If patients were found to have PHT by ECHO, a complete history was taken and an exercise/desaturation study on a treadmill was performed. Due to age and cooperation, the treadmill test was performed only on those patients greater than 3 years of age.
Pulsed Doppler echocardiograms were performed on the 21 patients. Twenty patients (aged 3.8 Ϯ 2.2 years), referred to the hospital for an echocardiogram that subsequently demonstrated no structural heart disease, were used as controls for the echocardiographic measurements. Sedation with chloral hydrate was used if the patient could not lie still for the procedure. There were no significant demographic differences between the study and control populations.
Doppler echocardioraphy was performed using either 5.0-or 3.5-MHz ultrasound. Sampling was performed in the main pulmonary artery midway between the pulmonary valve and the bifurcation of the pulmonary arteries in either the subcostal, sagittal, or parasternal short-axis view. Studies were recorded on 0.5-inch VHS videotape. From the spectral displays, the following measurements were made off-line: heart rate, the pre-ejection period (PEP), the acceleration time (AT), and the ejection time (ET). As shown in Figure 1 , PEP was defined as the time interval from onset of the electrocardiographic Q-wave to the initial systolic deflection of the pulmonary artery velocity curve. AT was defined as the time from the onset to the peak of the velocity curve. ET was defined as the interval between onset and termination of the velocity curve. These pulmonary flow indices were subsequently corrected for heart rate by dividing values by the square root of the R-R interval (PEPc, ATc, and ETc). Ratios of PEP/AT and AT/ET were also derived.
We defined PHT as values of PEP/AT, AT/ET, and ATc greater than two standard deviations from the means of the control population (PEP/AT Ն 0.76, AT/ET Յ 0.29, and ATc Յ 92 ms). These definitions are consistent with those cited in the literature that correlated echocardiographic data with cardiac catheterization data. PHT was diagnosed if at least two of the criteria were met. In addition, the presence of a mid-systolic notch on the echocardiogram, a finding specific for PHT, was noted. 14, 15 Electrocardiograms were performed on the 21 study patients and reviewed for signs of PHT. Evidence included: (a) right QRS axis deviation (RAD) with an axis of Ն110 o , or (b) right ventricular hypertrophy (RVH) with an upright T wave in V1, or (c) an R/S ratio greater than 1 in V1 in children more than 1 year of age.
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A full cardiopulmonary physical examination was performed. Signs felt to be indicative of PHT and right heart failure included tachypnea, arrhythmias, prominent P2 heart sound, narrowed splitting of S2 heart sound, tachycardia, diaphoresis, S3 or S4 heart sounds, tricuspid insufficiency murmur, pulmonary insufficiency murmur, hepatic enlargement and pain, pedal edema, and jugular venous distension (large "a" waves).
Those patients found to have PHT and those without PHT had a complete history. Parents were questioned specifically about the presence of dyspnea, wheezing, fatigue, exercise intolerance, feeding intolerance, failure to thrive in infancy, excessive napping, diaphoresis, or syncope. An exercise/oxygen desaturation study was performed on those found to have PHT and consisted of having the patient walk on a treadmill for 5 minutes and then rest for 5 minutes. Speed was set at 1.5 mph and increased 0.5 mph every minute as tolerated. Heart rate and oxygen saturation were taken before exercise and at each minute of exercise and rest. An adequate study was defined as one where the patient completed 5 minutes on the treadmill and reached a heart rate of 85% of maximum expected for age. Significant endpoints were defined as a decrease in oxygen saturation, at any point of the study, of greater than or equal to 5% from baseline.
Data are expressed as mean Ϯ standard deviation unless otherwise indicated. Comparisons among groups were conducted by multivariate analysis, unpaired Student t tests and chi-squared tests when appropriate. A probability level of 0.05 was the criterion for statistical significance.
RESULTS
Eight of 21 (38%) patients in the study group met the criteria for PHT (seven patients met all three criteria, while one met two of the criteria). Mean age at assessment of those patients with and without PHT did not differ (PHT ϭ 3.6 Ϯ 1.5 years versus No-PHT ϭ 2.9 Ϯ 1.3 years; p ϭ NS). Figure 2 (A-C) show the distribution of the echocardiographic data for the control group, the patients without PHT, and the patients with PHT. Six of 21 (29%) patients in the study group had a mid-systolic notch on the echocardiogram; all six patients were among those eight patients who met the criteria for PHT. data for the CDH group with and without PHT. No statistical differences were found between the two groups in regard to these variables. The 21 study patients underwent a complete cardiopulmonary physical examination. Two patients with PHT had a mildly prominent P2 heart sound. One patient without PHT was found to have a pectus excavatum and a grade II systolic ejection murmur. No other signs of PHT were found in this population on physical examination.
Six out of the 21 (29%) patients had either right axis deviation or right ventricular hypertrophy on the electrocardiogram. Two of the eight (25%) patients who met echocardiographic criteria for PHT had either RAD or RVH by ECG, whereas 4 of the 13 (31%) patients without evidence of PHT had either RAD or RVH by ECG ( p ϭ NS).
All study patients were evaluated with a complete history. By parental report, five of the eight patients with PHT had some degree of exercise intolerance at the time of the study. Seven of the eight patients had some degree of wheezing and were on bronchodilators at the time of the study. No other significant clinical symptoms were reported. None of the patients without PHT had any history of exercise intolerance, wheezing, or the need for bronchodilators. An exercise/ oxygen desaturation study was performed on seven of the eight children with PHT (one patient was too young for this test). Of the seven patients exercised on the treadmill, two desaturated 5% or greater from baseline. Neither patient desaturated to levels less than 85%.
DISCUSSION
Cardiac catheterization is the technique which remains the gold standard for assessing pulmonary pressures. As a surveillance technique, however, it remains costly and invasive. Echocardiography is considered a useful and accurate way to assess pulmonary artery pressures, because PHT alters the timing of pulmonic valve opening and closure. Patients with normal PAP show an almost symmetrical contour of acceleration and deceleration patterns, with peak velocity in midsystole. In PHT, there is a delayed systolic opening of the pulmonary valve (prolonged PEP), a more rapid increase in velocity following valve opening with an earlier peak velocity (shortened AT), and an earlier decrease in velocity (shortened ET) (see Figure 3, A and  B) . 16 -20 Research has shown that three measures, ATc, PEP/AT, and AT/ET, exhibit the best correlation with actual PAP when measured by catheterization. [11] [12] [13] In our study abnormal values for PAP were defined as greater than two standard deviations from control means. Using these criteria, 8 of 21 study patients were defined as having PHT by demonstrating at least two abnormal values; seven patients met all three criteria. Six of the patients had a mid-systolic notch, a highly specific finding for PHT, which most likely represents a transient reversal of the RV-PA pressure gradient. 19 As this study demonstrates, PHT persisted or recurred in a rather significant proportion (38%) of this ECMO/CDH population well be- 10 and Geiduschek et al., 9 the latter of which describe a fatality at 17 months of age. VanMeurs et al. 6 assessed similar aged ECMO/CDH patients for PHT using ECHO and found that 2 of 14 (14%) had elevated pulmonary artery pressures at follow-up. However, no specific echocardiographic data nor echocardiographic criteria for PHT were presented by these investigators. While there have been other general outcome studies of children with CDH who required ECMO, the majority of investigators have not performed rigorous assessments of cardiopulmonary function. 5, [21] [22] [23] The second aim of this study was to determine if any variables could predict which patients may be at highest risk for the development of PHT. In this evaluation, no correlations were found between any demographic, neonatal, or ECMO course variables and the presence of PHT. Even those patients with the most critical initial hospitalization (i.e., worse baseline blood gas values, longer ECMO runs, longer need for oxygen) were not at an increased risk for the future development of PHT.
The third aim of this study was to assess the efficacy of the physical examination and ECG as screening tools to detect PHT. Physical examination revealed only two of the patients with PHT in this study had any clinical signs of PHT, those being mildly accentuated P2 heart sounds. This absence of symptoms in the presence of documented PHT had been noted in other non-ECMO/CDH patients. 16, 24 PHT does not seem to become clinically apparent until a significant strain on the right heart occurs.
ECG has traditionally been used to screen for PHT. It is useful for the detection of RVH and RAD, both of which may be signs of elevated PAP. Consistent with the findings of Van Meurs et al., 6 our study showed that the ECG did not correlate with echocardiographic data. The ECG does not appear to be as useful because significant alterations in right ventricular structure and function most likely need to develop before ECG patterns become diagnostic. 16 Indeed, the sensitivity of detecting cor pulmonale by ECG has been shown to range from 28% to 75%. [25] [26] [27] [28] The findings of persistent ECG evidence of RVH/RAD in a significant proportion of this population (6 of 21, or 29%) and that of Van Meurs et al. 6 (43%) may in fact be related to cardiac malposition caused by the underlying pulmonary hypoplasia.
The fourth aim of this study was to assess the functional status of patients found to have PHT with a complete history and with modified pulmonary function testing in the form of an exercise/oxygen desaturation study on a treadmill. Parental reports of patient histories detail a significant clinical impairment. Five of the eight patients showed some degree of exercise intolerance and seven of the eight had wheezing and were being treated with bronchodilators. These symptoms most likely reflect persistent underlying pulmonary pathology. None of the patients without PHT had any symptoms of pulmonary hypertension by history.
Modified pulmonary function testing was performed because abnormal mechanical characteristics of remodeled vessels (shown to be present in CDH infants) are accentuated by exercise. As pulmonary blood flow within poorly distensible and maximally recruited pulmonary vessels increases during exercise, patients with PHT experience dramatic increases in pulmonary artery pressure. 29 The results of the oxygen desaturation study revealed decompensation in only two of the seven patients exercised. Unfortunately, due to the patients' ages and cooperation, more rigorous pulmonary function testing could not be performed. In the pre-ECMO era, however, select pulmonary studies of CDH populations revealed anatomic (decreased perfusion) but no functional (ventilatory) pulmonary abnormalities in infants beyond the neonatal period. 30 -37 Whether this holds true for this higher-risk population is unknown.
The two main pathophysiological features of CDH are pulmonary hypoplasia, associated with both a reduced size and number of pulmonary vessels, and/or pulmonary arteriolar vasoconstriction. While ECMO therapy addresses the acute reactive component of CDH, PHT may persist long after the ECMO run has ended because of either intermittent hypoxemia or residual anatomic abnormalities. In healthy infants, PAP decreases to half of systemic pressure by 24 hours after birth and reaches adult values in 6 to 8 weeks. 38 In CDH infants, however, there may be a progressive increase in vascular smooth muscle proliferation and, consequently, a concordant increase in PAP. 39 While some CDH/ECMO patients may experience worsening PHT, it is possible that the majority undergo a prolonged process of repair, resulting in eventual normalization of PAP. In that regard, Fitzgerald et al. 16 studied patients with chronic lung disease who initially had PHT and demonstrated an eventual resolution to normal PAP. Because our measurements were conducted at only one point in time, it is uncertain whether the pulmonary artery pressures of these children are resolving toward normal or worsening.
The absence of clinical predictors for PHT and the poor sensitivity and specificity of the physical examination and ECG in screening for this disease are not unexpected, because PHT may not become evident until there has been a significant degree of right heart failure. This being the case, the diagnosis of PHT, during the early stages of this disease when intervention could be critically important, will be missed if patients are not more thoroughly evaluated. Echocardiography is a useful noninvasive method of assessing which patients have elevated pulmonary artery pressures before these pressures become clinically evident. Serial echocardiography can further be used to establish the course of these pulmonary pressures. If elevated or even borderline pressures persist or worsen, cardiac catheterization may then be indicated to quantify the degree of pulmonary hypertension and to assess the response to various interventions that could potentially prevent the progression of PHT. Such interventions might include nighttime oxygen therapy and use of pulmonary vasodilators and calcium channel blockers. 40 -43 Ultimately, lung transplant may be the final option, as is now the case for one of our eight patients with PHT, who, before his follow-up echocardiogram, developed symptoms of PHT and was brought into the hospital for cardiac catheterization, which demonstrated severe PHT.
More research is necessary to assess the prevalence of persistent/ recurrent PHT in the ECMO/CDH and other ECMO populations, to understand the natural history of the changes in pulmonary pressures after severe pulmonary hypoplasia, and to better characterize the ability of echocardiography to diagnose PHT. Infants with PHT need to be identified early so functional status can be evaluated and appropriate therapy instituted.
